VIGILVESTLibrary
← Library

BIO-TECHNE Corp

TECH
SEC CIK 842023Price charts ↗
Writing the earnings story…

Financials

Revenue-1.5% YoY
$311.4M
Dec '23Mar '24Sep '24Dec '24Mar '25Sep '25Dec '25Mar '26
Net Income+126.0% YoY
$51.0M
Dec '23Mar '24Sep '24Dec '24Mar '25Sep '25Dec '25Mar '26
EPS (diluted)+128.6% YoY
$0.32
Dec '23Mar '24Sep '24Dec '24Mar '25Sep '25Dec '25Mar '26
Gross Margin-1.4% YoY
66.9%
Dec '23Mar '24Sep '24Dec '24Mar '25Sep '25Dec '25Mar '26
Quarter endingRevenueNet incomeEPS
Mar 2026$311.4M$51.0M$0.32
Dec 2025$295.9M$38.0M$0.24
Sep 2025$286.6M$38.2M$0.24
Mar 2025$316.2M$22.6M$0.14
Dec 2024$297.0M$34.9M$0.22
Sep 2024$289.5M$33.6M$0.21
Mar 2024$303.4M$49.1M$0.31
Dec 2023$272.6M$27.5M$0.17

Annual revenue

FY21FY22FY23FY24FY25

Source filings

Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.

Glossary

Revenue
Net income
EPS
Gross margin
Net margin
Fiscal year

Hover any underlined term for its definition.